YDES (YD Bio) Research & Development: $ Mil (TTM As of Dec. 2025)


YDES YD Bio Ltd YDES
12 GF Score
Price $2.35
! 1 Warning Sign
View Full Analysis

What is YD Bio Research & Development?

YD Bio YDES -2.89% 12 Research & Development is $ Mil as of Dec. 2025. GuruFocus rates YDES with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. YD Bio's Research & Development for the six months ended in Dec. 2025 was $0.00 Mil. YD Bio does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in Dec. 2025.

YD Bio  (NAS:YDES) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

YD Bio Research & Development Related Terms

YD Bio Research & Development Historical Data

* Premium members only.

The historical data trend for YD Bio's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

YD Bio Research & Development Chart

YD Bio Annual Data
Trend Dec23 Dec24 Dec25
Research & Development
0.00 0.49 1.60

YD Bio Semi-Annual Data
Dec24 Jun25 Dec25
Research & Development 0.00 0.00 0.00
YDES
12GF Score
YD Bio Ltd YDES
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

YD Bio Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $ Mil mean?
YD Bio (YDES) has a Research & Development of $ Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on YD Bio and its competitors.
Is YD Bio's Research & Development too high?
YD Bio's current Research & Development is $ Mil. Overall, YD Bio has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does YD Bio's Research & Development compare to NERV and CAMP?
YD Bio's Research & Development of $ Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on YD Bio and its competitors. YD Bio's current Research & Development is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is YD Bio stock overvalued right now?
YD Bio (YDES) has a current Research & Development of $ Mil. The current Research & Development is $ Mil. YD Bio's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For YD Bio (YDES), the current Research & Development is $ Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

YD Bio Business Description

Address No. 3, Xingnan Street, 12th Floor, Nangang District, Taipei City, TWN, 115001
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.
12GF Score

Get the complete analysis for YDES

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.35
Price